Atlas Capital Advisors Inc. Buys New Stake in HCA Healthcare, Inc. $HCA

Atlas Capital Advisors Inc. bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 5,378 shares of the company’s stock, valued at approximately $2,511,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in HCA. Norges Bank acquired a new position in HCA Healthcare in the fourth quarter valued at about $1,262,513,000. Life Cycle Investment Partners Ltd acquired a new position in HCA Healthcare in the fourth quarter valued at about $374,037,000. Viking Global Investors LP boosted its position in HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after buying an additional 690,773 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in HCA Healthcare by 4,545.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after buying an additional 649,058 shares in the last quarter. Finally, Danske Bank A S acquired a new position in HCA Healthcare in the third quarter valued at approximately $115,530,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

Shares of HCA stock opened at $387.25 on Friday. The company has a fifty day moving average price of $429.60 and a two-hundred day moving average price of $473.48. The stock has a market cap of $85.91 billion, a P/E ratio of 13.32, a P/E/G ratio of 1.23 and a beta of 1.12. HCA Healthcare, Inc. has a one year low of $330.00 and a one year high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. KeyCorp lowered their target price on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Wells Fargo & Company lowered their target price on shares of HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a research note on Monday, April 27th. Stephens lowered their price objective on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Weiss Ratings downgraded shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday. Finally, JPMorgan Chase & Co. lowered their price objective on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research report on Tuesday, May 19th. Fifteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $506.14.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.